Allergies News and Research

Latest Allergies News and Research

Tips for reducing allergens in yards

Prepping your yard this fall can give you a head start on spring landscaping, but it can also mean suffering from seasonal allergies seasonal allergies. Ragweed pollen and lingering mold can create double the symptoms for some allergy sufferers.

18 Sep 2013

Biocryst Wins Potentially $22M NIAID Contract To Develop Marburg Virus Disease Drug

...

17 Sep 2013

Childhood food allergies cost US nearly $25 billion a year

The overall cost of childhood food allergies was estimated at nearly $25 billion annually in a study of caregivers that quantified medical, out-of-pocket, lost work productivity and other expenses, according to a report published by JAMA Pediatrics, a JAMA Network publication.

17 Sep 2013

Understanding essential role of gut microbes in immune system

A new understanding of the essential role of gut microbes in the immune system may hold the key to dealing with some of the more significant health problems facing people in the world today, Oregon State University researchers say in a new analysis.

17 Sep 2013

Researchers identify new link between meal times and daily changes in immune system

A new link between meal times and daily changes in the immune system has been identified by UC San Francisco researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.

17 Sep 2013

Research findings bring scientists one step closer to preventing HIV infections

In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also showed where maraviroc, an HIV drug, attaches to cells and blocks HIV’s entry.

13 Sep 2013

Helper T cells important for AIDS vaccine development

A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.

13 Sep 2013

Proper precautions may help people with allergies enjoy the beautiful fall weather

As summer comes to a close, kids head back to school and preparation for fall begins, don't' forget to consider fall allergies. An estimated 35 million Americans suffer from allergies, which in the fall begin in late August and peak in September. For those with fall allergies, three triggers typically occur - ragweed, indoor allergens and infections.

12 Sep 2013

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

If the unseasonable heat that is blanketing the Midwest doesn't affect area residents, the highest mold count for the 2013 allergy reporting season will. Gottlieb Allergy Count, the official allergy count for the Midwest, reports the mold count today is 85,000, a high for 2013, and well over the 50,000 threshold that signals a dangerous air quality warning.

12 Sep 2013

Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced successful results from a phase II clinical study of its house dust mite allergy treatment (House Dust Mite-Synthetic Peptide Immuno-Regulatory Epitope [HDM-SPIRE] based on Circassia’s ToleroMune technology).

12 Sep 2013

Asthma experts united to tackle Europe's high asthma prevalence and death rates

Asthma experts from across Europe are uniting as part of a new partnership launched this week to tackle Europe's high asthma prevalence and death rates.

12 Sep 2013

ClinicalRM signs contract with NIH to provide broad spectrum of services for STI CTG Program

Clinical Research Management, Inc. (ClinicalRM) – a full-service Contract Research Organization (CRO) providing services for basic and applied research, clinical trials, and regulatory support – announced today it was awarded a contract by the Department of Health and Human Services, National Institutes of Health, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID).

12 Sep 2013

University student shares experiences about managing severe allergy

Ahead of the first term back for university undergraduates this month, the Anaphylaxis Campaign has released a short film on their YouTube channel.

11 Sep 2013

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more than 100 people, primarily in the Middle East.

10 Sep 2013

Parasites could be potential key to treating autoimmune diseases

There is a new weapon in the fight against autoimmune diseases such as Type 1 diabetes, rheumatoid arthritis, Crohn's disease and lupus, the common trait of which is an immune system that attacks its own organs and tissues.

10 Sep 2013

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

National Institutes of Health (NIH) scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

10 Sep 2013

Bronchial thermoplasty effective in long term

Researchers have shown that the asthma-control benefits of bronchial thermoplasty remain for as long as 5 years following treatment.

9 Sep 2013

Pharmathene presents new data from SparVax anthrax vaccine program at 2013 Bacillus conference

PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.

7 Sep 2013

Safety and health checklist to help kids avoid emergency room

With the school year underway, Children's Hospital Los Angeles experts have developed a safety and health checklist to help kids avoid the emergency room and develop productive extracurricular and learning activities to enhance the classroom experience. What do parents need to consider? Many symptoms of childhood conditions are often discovered in the classroom.

7 Sep 2013

Allergies News and Research

Latest Allergies News and Research

Tips for reducing allergens in yards

Biocryst Wins Potentially $22M NIAID Contract To Develop Marburg Virus Disease Drug

Childhood food allergies cost US nearly $25 billion a year

Understanding essential role of gut microbes in immune system

Researchers identify new link between meal times and daily changes in immune system

Research findings bring scientists one step closer to preventing HIV infections

Helper T cells important for AIDS vaccine development

Proper precautions may help people with allergies enjoy the beautiful fall weather

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study

Asthma experts united to tackle Europe's high asthma prevalence and death rates

ClinicalRM signs contract with NIH to provide broad spectrum of services for STI CTG Program

University student shares experiences about managing severe allergy

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Parasites could be potential key to treating autoimmune diseases

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

Bronchial thermoplasty effective in long term

Pharmathene presents new data from SparVax anthrax vaccine program at 2013 Bacillus conference

Safety and health checklist to help kids avoid emergency room

Industry Focus: Cell & Gene Therapy eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Allergies News and Research

Latest Allergies News and Research

Industry Focus: Cell & Gene Therapy eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in